<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02636712</url>
  </required_header>
  <id_info>
    <org_study_id>C1913</org_study_id>
    <nct_id>NCT02636712</nct_id>
  </id_info>
  <brief_title>Observation of ImageReady™ MR Conditional Pacing System in China</brief_title>
  <official_title>Observation of ImageReady™ MR Conditional Pacing System in China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To observe the safety and efficacy of ImageReady™ MR Conditional Pacing System in Chinese
      subjects
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Key Inclusion Criteria:

        1. Subject must have the Image Ready System as their initial (de novo) pacing system
           implant.

        2. Subject has a Class I or II indication for implantation of a pacemaker according to the
           CSPE guidelines.

        3. Subject is able and willing to undergo an MR scan.•

        4. Subject is willing and capable of providing informed consent and participating in all
           testing/ visits associated with this clinical study at the intervals defined by this
           protocol.

        5. Subject is age 18 or above.

      Key Exclusion Criteria

        1. Subject has or has had any pacing or ICD system implants.

        2. Subject has any implants or devices that are not suitable for MR scan.

        3. Subject is enrolled in any other concurrent study that might interfere with this study.

        4. Subject has documented life expectancy of less than 12 months.

        5. Women of childbearing potential who are or might be pregnant at the time of this study.

      Primary Safety Endpoint:

      MR Scan related Complication Free Rate Analyzed at MRI Visit +1 Month.

      Primary efficacy Endpoint:

        1. Pacing Threshold (at 0.5 ms pulse width) comparison pre and 1 Month post MR Scan: pacing
           threshold increase ≤ 0.5 V after scan.

        2. Sensed Amplitude comparison pre- and 1 Month post-MR Scan: sensed amplitude: ≥ 1.0 mV
           after scan, and ≥ 50% of that before scan.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 8, 2015</start_date>
  <completion_date type="Actual">November 2017</completion_date>
  <primary_completion_date type="Actual">March 16, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Participants Without Complications at MRI Visit + 1 Month.</measure>
    <time_frame>Within 1 month after the Pacemaker been implanted.</time_frame>
    <description>No one has any complications related MR Scan . So Complication-Free rate is 100%.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Participants Reporting an Increase in Pacing Thresholds ≤ 0.5V (at 0.5 ms) From Pre-MR Scan to MRI Visit + 1 Month Follow-up</measure>
    <time_frame>Pre-MR scan and 1 Month post-MR Scan.</time_frame>
    <description>The percentage of Participants Reporting an Increase in Pacing Thresholds ≤ 0.5V (at 0.5 ms) from Pre-MR Scan to MRI Visit + 1 Month Follow-up is 100 percent.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Participants With Atrial Sensed Amplitude at the MRI Visit + 1 Month Follow up Remains ≥ 1.0 mV and Above 50% of the Pre-MR Scan Value</measure>
    <time_frame>Pre-MR scan and 1 Month post-MR Scan.</time_frame>
    <description>The Percentage of participants with atrial sensed amplitude at the MRI Visit + 1 Month Follow up remains ≥ 1.0 mV and above 50% of the pre-MR scan value is 100%.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Participants With Ventricular Sensed Amplitudes at the MRI Visit + 1 Month Follow up Remains ≥ 5.0 mV and Above 50% of the Pre-MR Scan.</measure>
    <time_frame>Pre-MR scan and 1 Month post-MR Scan.</time_frame>
    <description>The percentage of participants with ventricular sensed amplitudes at the MRI Visit + 1 Month Follow up remains ≥ 5.0 mV and above 50% of the pre-MR scan is 100%.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Without System-related Complications</measure>
    <time_frame>Within 3 months after the Pacemaker been implanted.</time_frame>
    <description>No one has any complications related system occurred. So Complication-Free rate is 100%.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">10</enrollment>
  <condition>Arhythmia</condition>
  <condition>Atrioventricular Heart-block</condition>
  <condition>Chronic Bundle Branch or Branch Block</condition>
  <condition>Carotid Sinus Hypersensitivity Reaction Syndrome</condition>
  <condition>Vasovagal Syncope</condition>
  <arm_group>
    <arm_group_label>ImageReady™ MR Conditional Pacing System</arm_group_label>
    <description>Subject must have the ImageReady™ System as their initial (de novo) pacing system implant
Subject has a Class I or II indication for implantation of a pacemaker according to the CSPE guidelines</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ImageReady™ MR Conditional Pacing System</intervention_name>
    <arm_group_label>ImageReady™ MR Conditional Pacing System</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects included in the MR China Study should be selected from the investigator's general
        patient population indicated for single or dual chamber pacemaker implantation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject must have the ImageReady System as their initial (de novo) pacing system
             implant

          -  Subject has a Class I or II indication for implantation of a pacemaker according to
             the CSPE guidelines5

          -  Subject is able and willing to undergo an MR scan

          -  Subject is willing and capable of providing informed consent and participating in all
             testing/ visits associated with this clinical study at the intervals defined by this
             protocol

          -  Subject is age 18 or above

        Exclusion Criteria:

          -  Subject has or has had any pacing or ICD system implants

          -  Subject has any implants or devices that are not suitable for MR scan

          -  Subject is enrolled in any other concurrent study that might interfere with this study

          -  Subject has documented life expectancy of less than 12 months

          -  Women of childbearing potential who are or might be pregnant at the time of this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yangang Su, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai Zhongshan Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kejiang Cao, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>The First Affiliated Hospital with Nanjing Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jiangsu Province Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210029</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanghai Zhongshan Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Nazarian S, Hansford R, Roguin A, Goldsher D, Zviman MM, Lardo AC, Caffo BS, Frick KD, Kraut MA, Kamel IR, Calkins H, Berger RD, Bluemke DA, Halperin HR. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med. 2011 Oct 4;155(7):415-24. doi: 10.7326/0003-4819-155-7-201110040-00004.</citation>
    <PMID>21969340</PMID>
  </reference>
  <reference>
    <citation>Russo RJ. Determining the risks of clinically indicated nonthoracic magnetic resonance imaging at 1.5 T for patients with pacemakers and implantable cardioverter-defibrillators: rationale and design of the MagnaSafe Registry. Am Heart J. 2013 Mar;165(3):266-72. doi: 10.1016/j.ahj.2012.12.004. Epub 2013 Jan 28.</citation>
    <PMID>23453091</PMID>
  </reference>
  <reference>
    <citation>BSC data on file. 91022242_SAMURAI_FDA endpoint report_29JUN2015_Final_revAC.</citation>
  </reference>
  <reference>
    <citation>Shimizu T. [Explanation of JIS T 62570 Standard Practice for Marking Medical Devices and Other Items for Safety in the Magnetic Resonance Environment]. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2018;74(7):739-741. doi: 10.6009/jjrt.2018_JSRT_74.7.739. Japanese.</citation>
    <PMID>30033971</PMID>
  </reference>
  <reference>
    <citation>Wolf SM, Lawrenz FP, Nelson CA, Kahn JP, Cho MK, Clayton EW, Fletcher JG, Georgieff MK, Hammerschmidt D, Hudson K, Illes J, Kapur V, Keane MA, Koenig BA, Leroy BS, McFarland EG, Paradise J, Parker LS, Terry SF, Van Ness B, Wilfond BS. Managing incidental findings in human subjects research: analysis and recommendations. J Law Med Ethics. 2008 Summer;36(2):219-48, 211. doi: 10.1111/j.1748-720X.2008.00266.x. Review.</citation>
    <PMID>18547191</PMID>
  </reference>
  <reference>
    <citation>Kanal E, Barkovich AJ, Bell C, Borgstede JP, Bradley WG Jr, Froelich JW, Gilk T, Gimbel JR, Gosbee J, Kuhni-Kaminski E, Lester JW Jr, Nyenhuis J, Parag Y, Schaefer DJ, Sebek-Scoumis EA, Weinreb J, Zaremba LA, Wilcox P, Lucey L, Sass N; ACR Blue Ribbon Panel on MR Safety. ACR guidance document for safe MR practices: 2007. AJR Am J Roentgenol. 2007 Jun;188(6):1447-74.</citation>
    <PMID>17515363</PMID>
  </reference>
  <reference>
    <citation>张澍, 华伟, 黄德嘉, 王景峰, 吴立群, 杨杰孚, 曹克将, 黄从新, 王方正, 陈新: 植入性心脏起搏器治疗——目前认识和建议(2010年修订版). 中华心律失常学杂志 2010; 04:245-249. Shu Zhang, Wei Hua, Dejia Huang, Jingfeng Wang, Liqun Wu, Jiefu Wu, Kejiang Cao, Congxin Huang, Fangzheng Wang, Xin Chen: Implantable Cardiac Pacemaker therapy- Cognition and Suggestion Present ( updated version on 2010). Chinese Journal of Cardiac Arrhythmia, 2010; 04:245-249</citation>
  </reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>December 11, 2015</study_first_submitted>
  <study_first_submitted_qc>December 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2015</study_first_posted>
  <results_first_submitted>March 14, 2017</results_first_submitted>
  <results_first_submitted_qc>January 15, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 27, 2020</results_first_posted>
  <last_update_submitted>April 7, 2020</last_update_submitted>
  <last_update_submitted_qc>April 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syncope</mesh_term>
    <mesh_term>Syncope, Vasovagal</mesh_term>
    <mesh_term>Heart Block</mesh_term>
    <mesh_term>Atrioventricular Block</mesh_term>
    <mesh_term>Hypersensitivity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The recruitment has finished on 25 Dec 2015 and totally 10 patients.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>ImageReady™ System Indication</title>
          <description>Subject must have the ImageReady™ System as their initial (de novo) pacing system implant
Subject has a Class I or II indication for implantation of a pacemaker according to the CSPE guidelines
ImageReady™ MR Conditional Pacing System</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ImageReady™ System Indication</title>
          <description>Subject must have the ImageReady™ System as their initial (de novo) pacing system implant
Subject has a Class I or II indication for implantation of a pacemaker according to the CSPE guidelines
ImageReady™ MR Conditional Pacing System</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>Year</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.4" lower_limit="48" upper_limit="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>China</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants Without Complications at MRI Visit + 1 Month.</title>
        <description>No one has any complications related MR Scan . So Complication-Free rate is 100%.</description>
        <time_frame>Within 1 month after the Pacemaker been implanted.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ImageReady™ MR System Indication</title>
            <description>Subject must have the ImageReady™ System as their initial (de novo) pacing system implant
Subject has a Class I or II indication for implantation of a pacemaker according to the CSPE guidelines
ImageReady™ MR Conditional Pacing System</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Without Complications at MRI Visit + 1 Month.</title>
          <description>No one has any complications related MR Scan . So Complication-Free rate is 100%.</description>
          <units>percentage of paticipants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="69.2" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants Reporting an Increase in Pacing Thresholds ≤ 0.5V (at 0.5 ms) From Pre-MR Scan to MRI Visit + 1 Month Follow-up</title>
        <description>The percentage of Participants Reporting an Increase in Pacing Thresholds ≤ 0.5V (at 0.5 ms) from Pre-MR Scan to MRI Visit + 1 Month Follow-up is 100 percent.</description>
        <time_frame>Pre-MR scan and 1 Month post-MR Scan.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ImageReady™ System Indication</title>
            <description>Subject must have the ImageReady™ System as their initial (de novo) pacing system implant
Subject has a Class I or II indication for implantation of a pacemaker according to the CSPE guidelines
ImageReady™ MR Conditional Pacing System</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Reporting an Increase in Pacing Thresholds ≤ 0.5V (at 0.5 ms) From Pre-MR Scan to MRI Visit + 1 Month Follow-up</title>
          <description>The percentage of Participants Reporting an Increase in Pacing Thresholds ≤ 0.5V (at 0.5 ms) from Pre-MR Scan to MRI Visit + 1 Month Follow-up is 100 percent.</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="80.5" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants With Atrial Sensed Amplitude at the MRI Visit + 1 Month Follow up Remains ≥ 1.0 mV and Above 50% of the Pre-MR Scan Value</title>
        <description>The Percentage of participants with atrial sensed amplitude at the MRI Visit + 1 Month Follow up remains ≥ 1.0 mV and above 50% of the pre-MR scan value is 100%.</description>
        <time_frame>Pre-MR scan and 1 Month post-MR Scan.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ImageReady™ System Indication</title>
            <description>Subject must have the ImageReady™ System as their initial (de novo) pacing system implant
Subject has a Class I or II indication for implantation of a pacemaker according to the CSPE guidelines
ImageReady™ MR Conditional Pacing System</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Atrial Sensed Amplitude at the MRI Visit + 1 Month Follow up Remains ≥ 1.0 mV and Above 50% of the Pre-MR Scan Value</title>
          <description>The Percentage of participants with atrial sensed amplitude at the MRI Visit + 1 Month Follow up remains ≥ 1.0 mV and above 50% of the pre-MR scan value is 100%.</description>
          <units>percentage of paticipants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="59" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants With Ventricular Sensed Amplitudes at the MRI Visit + 1 Month Follow up Remains ≥ 5.0 mV and Above 50% of the Pre-MR Scan.</title>
        <description>The percentage of participants with ventricular sensed amplitudes at the MRI Visit + 1 Month Follow up remains ≥ 5.0 mV and above 50% of the pre-MR scan is 100%.</description>
        <time_frame>Pre-MR scan and 1 Month post-MR Scan.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ImageReady™ System Indication</title>
            <description>Subject must have the ImageReady™ System as their initial (de novo) pacing system implant
Subject has a Class I or II indication for implantation of a pacemaker according to the CSPE guidelines
ImageReady™ MR Conditional Pacing System</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Ventricular Sensed Amplitudes at the MRI Visit + 1 Month Follow up Remains ≥ 5.0 mV and Above 50% of the Pre-MR Scan.</title>
          <description>The percentage of participants with ventricular sensed amplitudes at the MRI Visit + 1 Month Follow up remains ≥ 5.0 mV and above 50% of the pre-MR scan is 100%.</description>
          <units>percentage of paticipants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="69.2" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Without System-related Complications</title>
        <description>No one has any complications related system occurred. So Complication-Free rate is 100%.</description>
        <time_frame>Within 3 months after the Pacemaker been implanted.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ImageReady™ System Indication</title>
            <description>Subject must have the ImageReady™ System as their initial (de novo) pacing system implant
Subject has a Class I or II indication for implantation of a pacemaker according to the CSPE guidelines
ImageReady™ MR Conditional Pacing System</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Without System-related Complications</title>
          <description>No one has any complications related system occurred. So Complication-Free rate is 100%.</description>
          <units>percentage of paticipants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="69.2" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Pre-Discharge, MR Scan Visit, MRI Visit+1 Week, MRI Visit+1 Month</time_frame>
      <group_list>
        <group group_id="E1">
          <title>ImageReady™ MR Conditional Pacing System</title>
          <description>Subject must have the ImageReady™ System as their initial (de novo) pacing system implant
Subject has a Class I or II indication for implantation of a pacemaker according to the CSPE guidelines
ImageReady™ MR Conditional Pacing System</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Yangang Su</name_or_title>
      <organization>Zhongshan Hospital</organization>
      <phone>+86 13788905096</phone>
      <email>suyangang111@163.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

